[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correction
April 10, 2006

Error in Financial Disclosure in: Conjugated Equine Estrogens and Coronary Heart Disease: The Women's Health Initiative

Arch Intern Med. 2006;166(7):759. doi:10.1001/archinte.166.7.759

Error in Financial Disclosure. In the Original Investigation by Hsia et al titled “Conjugated Equine Estrogens and Coronary Heart Disease: The Women's Health Initiative,” published in the February 13 issue of the ARCHIVES (2006;166:357-365), an error occurred in the financial disclosure. It should have appeared as follows: “Dr Langer received honoraria from Solvay Pharmaceuticals (Houston, Tex) and served as a consultant for Berlex (Montville, NJ), Monarch-King Pharmaceuticals (Bristol, Tenn), and Wyeth Pharmaceuticals (Collegeville, Pa). Dr Prentice received an honorarium from Wyeth Pharmaceuticals in 2004.” This correction was made previously to online versions of this article.

First Page Preview View Large
First page PDF preview
First page PDF preview
×